Rankings
▼
Calendar
DFTX Q4 2018 Earnings — Definium Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
DFTX
Definium Therapeutics, Inc.
$2B
Q4 2018 Earnings
Healthcare
Medical - Pharmaceuticals
Income Statement
Revenue
$0
Gross Profit
-$1,670
Operating Income
-$126,218
Net Income
-$126,218
EPS (Diluted)
$-0.36
QoQ Revenue Growth
NaN%
Balance Sheet
Total Assets
$3M
Total Liabilities
$92,409
Stockholders' Equity
$3M
Cash & Equivalents
$15,645
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$1,670
-$3,513
+52.5%
Operating Income
-$126,218
-$168,477
+25.1%
Net Income
-$126,218
-$165,383
+23.7%
← Q3 2018
All Quarters
Q1 2019 →